McMaster University and Kapoose Creek Bio awarded funding from Genome Canada to develop powerful synthetic biology tools
Fungi are prolific natural chemists and have been the source of some of the most important medicines in history, including penicillin, taxol and cyclosporine. However, producing active medicinal ingredients at scale for R&D has been a key barrier limiting further fungal drug discovery.
A new collaboration between McMaster University and Kapoose Creek Bio will seek to solve this issue by creating a flexible, scalable and cost-efficient synthetic biology platform that support the synthesis of diverse fungal molecules.
